DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Phase 2

Not yet recruiting

Conditions: Waldenstrom Macroglobulinemia

Interventions: Drug: Zanubrutinib
Drug: Bendamustine
Drug: Rituximab

First Posted Date: 2024-08-20

Last Posted Date: 2024-12-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 55

Registration Number: NCT06561347

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Combined Anabolic Therapy

Phase 4

Recruiting

Conditions: Osteoporosis, Postmenopausal
Osteoporosis

Interventions: Drug: Romosozumab
Drug: Teriparatide

First Posted Date: 2024-08-16

Last Posted Date: 2025-03-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT06558188

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

EB-OCT Biopsy Guidance of Lung Cancer

Not Applicable

Not yet recruiting

Conditions: Lung Cancer

Interventions: Device: Optical coherence tomography

First Posted Date: 2024-08-16

Last Posted Date: 2024-08-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 200

Registration Number: NCT06556680

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

Not Applicable

Not yet recruiting

Conditions: Obesity
Postpartum
Pregnancy
Anxiety
Hypertension
Diabetes
Depression

Interventions: Other: Facilitated Transition to Primary Care

First Posted Date: 2024-08-16

Last Posted Date: 2025-04-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1320

Registration Number: NCT06557005

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

Phase 2

Not yet recruiting

Conditions: HIV-1-infection
Frailty
Impaired Physical Function
Abdominal Obesity
Aging

Interventions: Drug: Placebo
Drug: Tesamorelin
Behavioral: Exercise

First Posted Date: 2024-08-15

Last Posted Date: 2025-04-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT06554717

Locations: 🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Retrospective and Prospective Natural History of Genetic Vasculopathies

Recruiting

Conditions: ACTA2
Multisystemic Smooth Muscle Dysfunction Syndrome

First Posted Date: 2024-08-13

Last Posted Date: 2025-05-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT06552052

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Developing a Resiliency Intervention to Support Healthcare Workers Engaged in the Provision of HIV Care

Not Applicable

Recruiting

Conditions: Burnout, Professional
Stress

Interventions: Behavioral: Adapted Relaxation Response Resiliency Program (3RP)

First Posted Date: 2024-08-12

Last Posted Date: 2025-01-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT06548035

Locations: 🇿🇦
MatCh Research nit (MRU), a Division of Wits Health Consort, Durban, South Africa

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Not Applicable

Not yet recruiting

Conditions: Sexual Dysfunction
Stem Cell Transplant Complications
Bone Marrow Transplant Complications

Interventions: Behavioral: Enhanced Usual Care Group
Behavioral: SHIFT Intervention Group

First Posted Date: 2024-08-07

Last Posted Date: 2024-08-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 300

Registration Number: NCT06541002

Locations: 🇺🇸
Massachusetts General Hospital (MGH), Boston, Massachusetts, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
University of Miami, Coral Gables, Florida, United States

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

Not Applicable

Recruiting

Conditions: Hepatocellular Carcinoma
Cirrhosis

Interventions: Behavioral: HARMONY
Other: Enhanced usual care

First Posted Date: 2024-08-07

Last Posted Date: 2024-11-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT06541990

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Early Phase 1

Recruiting

Conditions: Logopenic Progressive Aphasia
Alzheimer Disease
Mild Cognitive Impairment
Amnestic Symptoms

Interventions: Device: Active rTMS
Device: Sham rTMS

First Posted Date: 2024-08-05

Last Posted Date: 2025-04-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT06538311

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy